11 – 20 of 1321
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Fatal and nonfatal sharp force injuries to the limbs : a study of forensic autopsies in Sweden (2010-2019)
- Contribution to journal › Article
-
Mark
REACtiVe-2 : phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
- Contribution to journal › Article
-
Mark
Underdiagnosis of positive resection margins and synchronous peritoneal metastases in locally advanced colon cancer : histopathological reassessment of primary resection in the COLOPEC trial
- Contribution to journal › Article
-
Mark
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes
- Contribution to journal › Article
-
Mark
Longer daily oxygen use associates with more adverse events, symptoms, and worse health status in long-term oxygen therapy
- Contribution to journal › Article
-
Mark
Fenestrated and Branched Endovascular Aortic Arch Repair Outcomes in Female Patients : A Retrospective Multicentre Analysis
- Contribution to journal › Article
-
Mark
Cardiovascular disease and beta-cell function at diagnosis of serologically defined adult-onset type 1 and type 2 diabetes in two Swedish cohorts 15 years apart
- Contribution to journal › Article
-
Mark
Evaluation Of Handheld Point-of-Care-Ultrasound (POCUS) in Screening for Abdominal Aortic Aneurysm in Men : A Comparative, Cohort Study
- Contribution to journal › Article
-
Mark
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2) : a multicentre, participant-masked, registry-based, randomised controlled trial
- Contribution to journal › Article
-
Mark
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1) : a multicentre, participant-masked, registry-based, randomised controlled trial
- Contribution to journal › Article
